Arana Therapeutics Ltd Report issue

For profit Phase 2
Founded: Redwood City CA United States (2003)
Status: Acquired by Cephalon (2009) → now Teva (2011)

Organization Overview

First Clinical Trial
2009
NCT00854685
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

placulumab (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 2)

Arthritis, Rheumatoid (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1